Despite the COVID-19 global pandemic, 2020 was an eventful year in the life sciences and technology sector mainly due to the popularity rise of the special purpose acquisition companies IPOs SPACs on Wall Street. SPACs have increasingly gained popularity because they give companies the option of going public without dealing with
Life sciences-also known as biosciences- is a constitution of various science branches such as biology, ecology, medicine, or anthropology. These sciences are categorized as
The year 2020 has been a unique one for most VC fields on a global level. Organizations in the life sciences industry have...
Ever since the arrival of the pandemic, there have been efforts towards creating a suitable vaccine. Since the virus is showing no...
Emerging life sciences company, Wesana Health has closed its $4 million convertible note financing round. London-based firm The Conscious Fund (TCF) led...
When we compare life sciences and healthcare to other industries, the strategy in the former is much more fragmented. The pricing practices are also relatively unbalanced while the product cycle is quite long as well.
Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense leadership skills, Dr. James holds over 25 years of experience in the pharmaceutical, venture capital, and biotech sectors. He also possesses medical expertise in antibody therapeutics and oncology.
The advent of coronavirus has threatened almost every job industry operating in the U.S. This has further affected the job market worldwide while creating a sense of fear among employees. Fortunately, the life sciences industry seems to be immune to the pandemic woes. The global deals within this sector accounted for $467 billion from 2013 to 2020.
It would be an understatement to say that 2020 was a difficult year for everyone. Most of the world has been living in perpetual fear for several months. This includes the economic downturn various industries have faced including agriculture, energy, tourism, and retail businesses.
Decibel Therapeutics Inc., a Boston-based organization dedicated to treating hearing and balance disorders, is on the verge of another gene therapy breakthrough.